Buddleja officinalis suppresses high glucose-induced vascular smooth muscle cell proliferation: Role of mitogen-activated protein kinases, nuclear factor- κB and matrix metalloproteinases

Experimental Biology and Medicine

Volumn 235, Issue 2, 2010, Pages 247-255

  Lee, Yun Jung ^a   Kim, Jin Sook ^b   Kang, Dae Gill ^a   Lee, Ho Sub ^a  

^a Wonkwang University   (South Korea)

^b Korea Institute of Oriental Medicine (KIOM)   (South Korea)

Author keywords

Aortic smooth muscle cell; Buddleja officinalis; MAPK; MMP; NF B; Proliferation

Indexed keywords

BUDDLEJA OFFICINALIS EXTRACT; CELL CYCLE PROTEIN; GELATINASE A; GELATINASE B; GLUCOSE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MATRIX METALLOPROTEINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; PLANT EXTRACT; STRESS ACTIVATED PROTEIN KINASE; THYMIDINE; UNCLASSIFIED DRUG;

AORTA MEDIA; ARTICLE; ATHEROSCLEROSIS; BUDDLEJA; BUDDLEJA OFFICINALIS; CELL CULTURE; CELL PROLIFERATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DOSE RESPONSE; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; HUMAN CELL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER;

ACTIVE TRANSPORT, CELL NUCLEUS; ATHEROSCLEROSIS; BASE SEQUENCE; BUDDLEJA; CELL PROLIFERATION; CELLS, CULTURED; DIABETIC ANGIOPATHIES; DNA PRIMERS; GLUCOSE; HUMANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MATRIX METALLOPROTEINASES; MITOGEN-ACTIVATED PROTEIN KINASES; MUSCLE, SMOOTH, VASCULAR; NF-KAPPA B; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PLANT EXTRACTS; PLANTS, MEDICINAL; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION;

BUDDLEJA OFFICINALIS;

EID: 77649152285     PISSN: 15353702     EISSN: 15353699     Source Type: Journal    
DOI: 10.1258/ebm.2009.009222     Document Type: Article

References (37)

1. Ruderman NB, Haudenschild C. Diabetes as an atherogenic factor. Prog Cardiovasc Dis 1984;26:373-412
2. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993;362:801-9
3. Maile LA, Capps BE, Ling Y, Xi G, Clemmons DR. Hyperglycemia alters the responsiveness of smooth muscle cells to insulin-like growth factor-I. Endocrinology 2007;148:2435-43
4. Suh SJ, Jin UH, KimSH, ChangHW, Son JK, Lee SH, Son KH,KimCH. Ochnaflavone inhibits TNF-alpha-induced human VSMC proliferation via regulation of cell cycle,ERK1/2, andMMP-9. J Cell Biochem 2006;99:1298-307
5. Sherr CJ. Cancer cell cycles. Science 1996;274:1672-7
6. Toyoshima H, Hunter T. p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21. Cell 1994;78:67-74
7. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 2001;414:813-20
8. Yao JS, Chen Y, Zhai W, Xu K, Young WL, Yang GY. Minocycline exerts multiple inhibitory effects on vascular endothelial growth factor-induced smooth muscle cell migration: the role of ERK1/2, PI3K, and matrix metalloproteinases. Circ Res 2004;95:364-71
9. Li L, Mamputu JC, Wiernsperger N, Renier G. Signaling pathways involved in human vascular smooth muscle cell proliferation and matrix metalloproteinase-2 expression induced by leptin: inhibitory effect of metformin. Diabetes 2005;54:2227-34
10. Piao MS, Kim MR, Lee DG, Park Y, Hahm KS, Moon YH, Woo ER. Antioxidative constituents from Buddleia officinalis. Arch Pharm Res 2003;26:453-7
11. Houghton PJ, Mensah AY, Iessa N, Hong LY. Terpenoids in Buddleja: relevance to chemosystematics, chemical ecology and biological activity. Phytochemistry 2003;64:385-93
12. Lee YJ, Kang DG, Kim JS, Lee HS. Effect of Buddleja officinalis on high-glucose-induced vascular inflammation in human umbilical vein endothelial cells. Exp Biol Med (Maywood) 2008;233:694-700
13. Lee YJ, Kang DG, Kim JS, Lee HS. Buddleja officinalis inhibits high glucose-induced matrix metalloproteinase activity in human umbilical vein endothelial cells. Phytother Res 2008;22:1655-9
14. Sheng GQ, Zhang JR, Pu XP, Ma J, Li CL. Protective effect of verbascoside on 1-methyl-4-phenylpyridinium ion-induced neurotoxicity in PC12 cells. Eur J Pharmacol 2002;451:119-24
15. Pruzanski W, Stefanski E, Kopilov J, Kuksis A. Mitogenic effect of lipoproteins on human vascular smooth muscle cells: the impact of hydrolysis by gr II A phospholipase A(2). Lab Invest 2001;81:757-65
16. Gabelman BM, Emerman JT. Effects of estrogen, epidermal growth factor, and transforming growth factor-alpha on the growth of human breast epithelial cells in primary culture. Exp Cell Res 1992;201:113-8
17. Herron GS, Banda MJ, Clark EJ, Gavrilovic J, Werb Z. Secretion of metalloproteinases by stimulated capillary endothelial cells. II. Expression of collagenase and stromelysin activities is regulated by endogenous inhibitors. J Biol Chem 1986;261:2814-8
18. Liu B, Bhat M, Nagaraj RH. aB-crystallin inhibits glucose-induced apoptosis in vascular endothelial cells. Biochem Biophys Res Commun 2004;321:254-8
19. Dschietzig T, Richter C, Pfannenschmidt G, Bartsch C, Laule M, Baumann G, Stangl K. Dexamethasone inhibits stimulation of pulmonary endothelins by proinflammatory cytokines: possible involvement of a nuclear factor kappa B dependent mechanism. Intensive Care Med 2001;27:751-6
20. Kim JY, Jung KS, Jeong HG. Suppressive effects of the kahweol and cafestol on cyclooxygenase-2 expression in macrophages. FEBS Lett 2004;569:321-6
21. Kunsch C, Medford RM. Oxidative stress as a regulator of gene expression in the vasculature. Circ Res 1999;85:753-66
22. Deem TL, Cook-Mills JM. Vascular cell adhesion molecule 1 (VCAM-1) activation of endothelial cell matrix metalloproteinases: role of reactive oxygen species. Blood 2004;104:2385-93
23. Gerrity RG, Natarajan R, Nadler JL, Kimsey T. Diabetes-induced accelerated atherosclerosis in swine. Diabetes 2001;50:1654-65
24. Mohler ER III, Sarov-Blat L, Shi Y, Hamamdzic D, Zalewski A, Macphee C, Llano R, Pelchovitz D, Mainigi SK, Osman H, Hallman T, Steplewski K, Gertz Z, Lu MM, Wilensky RL. Site-specific atherogenic gene expression correlates with subsequent variable lesion development in coronary and peripheral vasculature. Arterioscler Thromb Vasc Biol 2008;28:850-5
25. Zhang L, Zalewski A, Liu Y, Mazurek T, Cowan S, Martin JL, Hofmann SM, Vlassara H, Shi Y. Diabetes-induced oxidative stress and low-grade inflammation in porcine coronary arteries. Circulation 2003;108:472-8
26. Weiss RH, Joo A, Randour C. p21Waf1/Cip1 is an assembly factor required for platelet-derived growth factor-induced vascular smooth muscle cell proliferation. J Biol Chem 2000;275:10285-90
27. Yang JG, Shen YH, Hong Y, Jin FH, Zhao SH, Wang MC, Shi XJ, Fang XX. Stir-baked Fructus gardeniae (L.) extracts inhibit matrix metalloproteinases and alter cell morphology. J Ethnopharmacol 2008;117:285-9
28. Loo WT, Chen JP, Chow LW, Chou JW. Effects of Shugansanjie Tang on matrix metalloproteinases 1, 3 and 9 and telomerase reverse transcriptase expression in human breast cells in vitro. Biomed Pharmacother 2007;61:601-5
29. Ha KT, Lee TK, Kwak KH, Kim JK, Kim DI, Choi DY, Kim CH. Inhibitory effect of Cho-Deung-San on human aortic smooth muscle cell migration induced by TNF-alpha through inhibition of matrix metalloproteinase-2 and -9 activity. Vasc Pharmacol 2004; 41:83-90
30. Galis ZS, Johnson C, Godin D, Magid R, Shipley JM, Senior RM, Ivan E. Targeted disruption of the matrix metalloproteinase-9 gene impairs smooth muscle cell migration and geometrical arterial remodeling. Circ Res 2002;91:852-9
31. Lee SO, Jeong YJ, Yu MH, Lee JW, Hwangbo MH, Kim CH, Lee IS. Wogonin suppresses TNF-alpha-induced MMP-9 expression by blocking the NF-kappaB activation via MAPK signaling pathways in human aortic smooth muscle cells. Biochem Biophys Res Commun 2006;351:118-25
32. Kunsch C, Medford RM. Oxidative stress as a regulator of gene expression in the vasculature. Circ Res 1999;85:753-66
33. Deem TL, Cook-Mills JM. Vascular cell adhesion molecule 1 (VCAM-1) activation of endothelial cell matrix metalloproteinases: role of reactive oxygen species. Blood 2004;104:2385-93
34. Lyle AN, Griendling KK. Modulation of vascular smooth muscle signaling by reactive oxygen species. Physiology (Bethesda) 2006;21:269-80
35. Clempus RE, Griendling KK. Reactive oxygen species signaling in vascular smooth muscle cells. Cardiovasc Res 2006;71:216-25
36. Thurberg BL, Collins T. The nuclear factor-kappa B/inhibitor of kappa B autoregulatory system and atherosclerosis. Curr Opin Lipidol 1998;9:387-96
37. Karin M, Ben-Neriah Y. Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity. Annu Rev Immunol 2000;18:621-63 38 Tak PP, Firestein GS. NF-kappaB: a key role in inflammatory diseases. J Clin Invest 2001;107:7-11